Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

 Zylet (Loteprednol Etabonate & Tobramycin) Ophthalmic Suspension
Company:  Bausch & Lomb, Inc.
Application No.:  050804 (formerly) 021675)
Approval Date: 12/14/2004

 

Date created: June 232005

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-